Bridgewater Associates’s Innoviva INVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-145,104
Closed -$1.85M 778
2023
Q2
$1.85M Sell
145,104
-399
-0.3% -$4.99K 0.01% 477
2023
Q1
$1.64M Buy
+145,503
New +$1.77M 0.01% 491

Other funds holding INVA

Bridgewater Associates's INVA Position: Q3 2023 in Review

Bridgewater Associates sold out of Innoviva (INVA) in Q3 2023, closing a stake of 145,104 shares — an estimated $1.85M sold.

Bridgewater Associates first reported a position in INVA in Q1 2023 and held it in 2 quarters. The position peaked at $1.85M in Q2 2023. 193 funds tracked by Wall St. Rank hold INVA as of Q3 2023.

  • Bridgewater Associates reported no remaining Innoviva position as of Q3 2023 after selling out during the quarter.
  • Bridgewater Associates sold 145,104 Innoviva shares in Q3 2023, an estimated $1.85M.
  • Bridgewater Associates first reported a position in Innoviva in Q1 2023 and held it in 2 quarters.
  • Bridgewater Associates's Innoviva position peaked at $1.85M in Q2 2023.
  • 193 funds tracked by Wall St. Rank held Innoviva as of Q3 2023.

Based on Bridgewater Associates's 13F filing for Q3 2023, filed 13 Nov 2023.